Will The Magnificent 7 Stocks Go Up This Year?
2025 was another banner year for the Magnificent Seven stocks,…
Sell
38
CCM Quote, Financials, Valuation and Earnings
Last price:
$5.08
Seasonality move
:
0.23%
Day range:
$4.33 - $4.91
52-week range:
$3.54 - $10.77
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.40x
P/B ratio:
--
Volume:
13.3K
Avg. volume:
9.1K
1-year change:
-11.7%
Market cap:
$20.3M
Revenue:
$53.4M
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
CCM
Concord Medical Services Holdings Ltd.
|
-- | -- | -- | -- | -- |
|
CASI
CASI Pharmaceuticals, Inc.
|
-- | -- | -100% | -- | $4.00 |
|
CPHI
China Pharma Holdings, Inc.
|
-- | -- | -- | -- | -- |
|
RDY
Dr. Reddy's Laboratories Ltd.
|
$930.2M | $0.19 | -2.63% | 3.83% | $14.69 |
|
SVA
Sinovac Biotech Ltd.
|
-- | -- | -- | -- | -- |
|
ZLAB
Zai Lab Ltd.
|
$126.7M | -$0.41 | 16.18% | -46.43% | $47.99 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
CCM
Concord Medical Services Holdings Ltd.
|
$4.68 | -- | $20.3M | -- | $0.00 | 0% | 0.40x |
|
CASI
CASI Pharmaceuticals, Inc.
|
$1.10 | $4.00 | $22.6M | -- | $0.00 | 0% | 0.64x |
|
CPHI
China Pharma Holdings, Inc.
|
$1.31 | -- | $4.3M | -- | $0.00 | 0% | 1.06x |
|
RDY
Dr. Reddy's Laboratories Ltd.
|
$13.35 | $14.69 | $11.1B | 16.34x | $0.09 | 0.7% | 2.80x |
|
SVA
Sinovac Biotech Ltd.
|
$6.47 | -- | $464.9M | -- | $55.00 | 0% | 1.50x |
|
ZLAB
Zai Lab Ltd.
|
$18.50 | $47.99 | $2B | -- | $0.00 | 0% | 4.49x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
CCM
Concord Medical Services Holdings Ltd.
|
273.84% | -1.548 | 77.28% | 0.19x |
|
CASI
CASI Pharmaceuticals, Inc.
|
-274.41% | -0.497 | 55.28% | 0.19x |
|
CPHI
China Pharma Holdings, Inc.
|
29.58% | -1.111 | 56.09% | 0.09x |
|
RDY
Dr. Reddy's Laboratories Ltd.
|
14.04% | -0.123 | 5.65% | 1.12x |
|
SVA
Sinovac Biotech Ltd.
|
3.46% | 6.279 | 12.91% | 11.22x |
|
ZLAB
Zai Lab Ltd.
|
22.4% | -0.105 | 5.85% | 2.56x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
CCM
Concord Medical Services Holdings Ltd.
|
-- | -- | -7.49% | -19.78% | -- | -- |
|
CASI
CASI Pharmaceuticals, Inc.
|
$706K | -$10.2M | -405.32% | -70405.41% | -333.14% | -- |
|
CPHI
China Pharma Holdings, Inc.
|
-$257.6K | -$628.1K | -29.08% | -43.41% | -83.07% | -$277.6K |
|
RDY
Dr. Reddy's Laboratories Ltd.
|
$517.5M | $178.5M | 14.9% | 17.11% | 17.71% | $49.2M |
|
SVA
Sinovac Biotech Ltd.
|
-- | -- | -1.02% | -1.05% | -- | -- |
|
ZLAB
Zai Lab Ltd.
|
$69.3M | -$48.9M | -21.74% | -26.7% | -42.05% | -$44.5M |
Concord Medical Services Holdings Ltd. vs. Competitors
-
Which has Higher Returns CCM or CASI?
CASI Pharmaceuticals, Inc. has a net margin of -- compared to Concord Medical Services Holdings Ltd.'s net margin of -353.92%. Concord Medical Services Holdings Ltd.'s return on equity of -19.78% beat CASI Pharmaceuticals, Inc.'s return on equity of -70405.41%.
Company Gross Margin Earnings Per Share Invested Capital CCMConcord Medical Services Holdings Ltd.-- -- $727.8M CASICASI Pharmaceuticals, Inc.22.96% -$0.68 -$6.9M -
What do Analysts Say About CCM or CASI?
Concord Medical Services Holdings Ltd. has a consensus price target of --, signalling upside risk potential of 156.41%. On the other hand CASI Pharmaceuticals, Inc. has an analysts' consensus of $4.00 which suggests that it could grow by 263.64%. Given that CASI Pharmaceuticals, Inc. has higher upside potential than Concord Medical Services Holdings Ltd., analysts believe CASI Pharmaceuticals, Inc. is more attractive than Concord Medical Services Holdings Ltd..
Company Buy Ratings Hold Ratings Sell Ratings CCMConcord Medical Services Holdings Ltd.0 0 0 CASICASI Pharmaceuticals, Inc.1 0 0 -
Is CCM or CASI More Risky?
Concord Medical Services Holdings Ltd. has a beta of -1.272, which suggesting that the stock is 227.222% less volatile than S&P 500. In comparison CASI Pharmaceuticals, Inc. has a beta of 0.825, suggesting its less volatile than the S&P 500 by 17.505%.
-
Which is a Better Dividend Stock CCM or CASI?
Concord Medical Services Holdings Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CASI Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Concord Medical Services Holdings Ltd. pays -- of its earnings as a dividend. CASI Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CCM or CASI?
Concord Medical Services Holdings Ltd. quarterly revenues are --, which are smaller than CASI Pharmaceuticals, Inc. quarterly revenues of $3.1M. Concord Medical Services Holdings Ltd.'s net income of -- is lower than CASI Pharmaceuticals, Inc.'s net income of -$10.9M. Notably, Concord Medical Services Holdings Ltd.'s price-to-earnings ratio is -- while CASI Pharmaceuticals, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Concord Medical Services Holdings Ltd. is 0.40x versus 0.64x for CASI Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CCMConcord Medical Services Holdings Ltd.0.40x -- -- -- CASICASI Pharmaceuticals, Inc.0.64x -- $3.1M -$10.9M
-
Which has Higher Returns CCM or CPHI?
China Pharma Holdings, Inc. has a net margin of -- compared to Concord Medical Services Holdings Ltd.'s net margin of -86.16%. Concord Medical Services Holdings Ltd.'s return on equity of -19.78% beat China Pharma Holdings, Inc.'s return on equity of -43.41%.
Company Gross Margin Earnings Per Share Invested Capital CCMConcord Medical Services Holdings Ltd.-- -- $727.8M CPHIChina Pharma Holdings, Inc.-34.07% -$0.17 $12.1M -
What do Analysts Say About CCM or CPHI?
Concord Medical Services Holdings Ltd. has a consensus price target of --, signalling upside risk potential of 156.41%. On the other hand China Pharma Holdings, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Concord Medical Services Holdings Ltd. has higher upside potential than China Pharma Holdings, Inc., analysts believe Concord Medical Services Holdings Ltd. is more attractive than China Pharma Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CCMConcord Medical Services Holdings Ltd.0 0 0 CPHIChina Pharma Holdings, Inc.0 0 0 -
Is CCM or CPHI More Risky?
Concord Medical Services Holdings Ltd. has a beta of -1.272, which suggesting that the stock is 227.222% less volatile than S&P 500. In comparison China Pharma Holdings, Inc. has a beta of 1.033, suggesting its more volatile than the S&P 500 by 3.259%.
-
Which is a Better Dividend Stock CCM or CPHI?
Concord Medical Services Holdings Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. China Pharma Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Concord Medical Services Holdings Ltd. pays -- of its earnings as a dividend. China Pharma Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CCM or CPHI?
Concord Medical Services Holdings Ltd. quarterly revenues are --, which are smaller than China Pharma Holdings, Inc. quarterly revenues of $756.2K. Concord Medical Services Holdings Ltd.'s net income of -- is lower than China Pharma Holdings, Inc.'s net income of -$651.5K. Notably, Concord Medical Services Holdings Ltd.'s price-to-earnings ratio is -- while China Pharma Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Concord Medical Services Holdings Ltd. is 0.40x versus 1.06x for China Pharma Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CCMConcord Medical Services Holdings Ltd.0.40x -- -- -- CPHIChina Pharma Holdings, Inc.1.06x -- $756.2K -$651.5K
-
Which has Higher Returns CCM or RDY?
Dr. Reddy's Laboratories Ltd. has a net margin of -- compared to Concord Medical Services Holdings Ltd.'s net margin of 16.2%. Concord Medical Services Holdings Ltd.'s return on equity of -19.78% beat Dr. Reddy's Laboratories Ltd.'s return on equity of 17.11%.
Company Gross Margin Earnings Per Share Invested Capital CCMConcord Medical Services Holdings Ltd.-- -- $727.8M RDYDr. Reddy's Laboratories Ltd.51.32% $0.20 $4.7B -
What do Analysts Say About CCM or RDY?
Concord Medical Services Holdings Ltd. has a consensus price target of --, signalling upside risk potential of 156.41%. On the other hand Dr. Reddy's Laboratories Ltd. has an analysts' consensus of $14.69 which suggests that it could grow by 10.03%. Given that Concord Medical Services Holdings Ltd. has higher upside potential than Dr. Reddy's Laboratories Ltd., analysts believe Concord Medical Services Holdings Ltd. is more attractive than Dr. Reddy's Laboratories Ltd..
Company Buy Ratings Hold Ratings Sell Ratings CCMConcord Medical Services Holdings Ltd.0 0 0 RDYDr. Reddy's Laboratories Ltd.2 2 1 -
Is CCM or RDY More Risky?
Concord Medical Services Holdings Ltd. has a beta of -1.272, which suggesting that the stock is 227.222% less volatile than S&P 500. In comparison Dr. Reddy's Laboratories Ltd. has a beta of 0.374, suggesting its less volatile than the S&P 500 by 62.627%.
-
Which is a Better Dividend Stock CCM or RDY?
Concord Medical Services Holdings Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Dr. Reddy's Laboratories Ltd. offers a yield of 0.7% to investors and pays a quarterly dividend of $0.09 per share. Concord Medical Services Holdings Ltd. pays -- of its earnings as a dividend. Dr. Reddy's Laboratories Ltd. pays out 8.91% of its earnings as a dividend. Dr. Reddy's Laboratories Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios CCM or RDY?
Concord Medical Services Holdings Ltd. quarterly revenues are --, which are smaller than Dr. Reddy's Laboratories Ltd. quarterly revenues of $1B. Concord Medical Services Holdings Ltd.'s net income of -- is lower than Dr. Reddy's Laboratories Ltd.'s net income of $163.4M. Notably, Concord Medical Services Holdings Ltd.'s price-to-earnings ratio is -- while Dr. Reddy's Laboratories Ltd.'s PE ratio is 16.34x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Concord Medical Services Holdings Ltd. is 0.40x versus 2.80x for Dr. Reddy's Laboratories Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CCMConcord Medical Services Holdings Ltd.0.40x -- -- -- RDYDr. Reddy's Laboratories Ltd.2.80x 16.34x $1B $163.4M
-
Which has Higher Returns CCM or SVA?
Sinovac Biotech Ltd. has a net margin of -- compared to Concord Medical Services Holdings Ltd.'s net margin of --. Concord Medical Services Holdings Ltd.'s return on equity of -19.78% beat Sinovac Biotech Ltd.'s return on equity of -1.05%.
Company Gross Margin Earnings Per Share Invested Capital CCMConcord Medical Services Holdings Ltd.-- -- $727.8M SVASinovac Biotech Ltd.-- -- $11.8B -
What do Analysts Say About CCM or SVA?
Concord Medical Services Holdings Ltd. has a consensus price target of --, signalling upside risk potential of 156.41%. On the other hand Sinovac Biotech Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Concord Medical Services Holdings Ltd. has higher upside potential than Sinovac Biotech Ltd., analysts believe Concord Medical Services Holdings Ltd. is more attractive than Sinovac Biotech Ltd..
Company Buy Ratings Hold Ratings Sell Ratings CCMConcord Medical Services Holdings Ltd.0 0 0 SVASinovac Biotech Ltd.0 0 0 -
Is CCM or SVA More Risky?
Concord Medical Services Holdings Ltd. has a beta of -1.272, which suggesting that the stock is 227.222% less volatile than S&P 500. In comparison Sinovac Biotech Ltd. has a beta of 0.774, suggesting its less volatile than the S&P 500 by 22.623%.
-
Which is a Better Dividend Stock CCM or SVA?
Concord Medical Services Holdings Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Sinovac Biotech Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $55.00 per share. Concord Medical Services Holdings Ltd. pays -- of its earnings as a dividend. Sinovac Biotech Ltd. pays out -328.35% of its earnings as a dividend.
-
Which has Better Financial Ratios CCM or SVA?
Concord Medical Services Holdings Ltd. quarterly revenues are --, which are smaller than Sinovac Biotech Ltd. quarterly revenues of --. Concord Medical Services Holdings Ltd.'s net income of -- is lower than Sinovac Biotech Ltd.'s net income of --. Notably, Concord Medical Services Holdings Ltd.'s price-to-earnings ratio is -- while Sinovac Biotech Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Concord Medical Services Holdings Ltd. is 0.40x versus 1.50x for Sinovac Biotech Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CCMConcord Medical Services Holdings Ltd.0.40x -- -- -- SVASinovac Biotech Ltd.1.50x -- -- --
-
Which has Higher Returns CCM or ZLAB?
Zai Lab Ltd. has a net margin of -- compared to Concord Medical Services Holdings Ltd.'s net margin of -30.98%. Concord Medical Services Holdings Ltd.'s return on equity of -19.78% beat Zai Lab Ltd.'s return on equity of -26.7%.
Company Gross Margin Earnings Per Share Invested Capital CCMConcord Medical Services Holdings Ltd.-- -- $727.8M ZLABZai Lab Ltd.59.62% -$0.33 $979.3M -
What do Analysts Say About CCM or ZLAB?
Concord Medical Services Holdings Ltd. has a consensus price target of --, signalling upside risk potential of 156.41%. On the other hand Zai Lab Ltd. has an analysts' consensus of $47.99 which suggests that it could grow by 159.4%. Given that Zai Lab Ltd. has higher upside potential than Concord Medical Services Holdings Ltd., analysts believe Zai Lab Ltd. is more attractive than Concord Medical Services Holdings Ltd..
Company Buy Ratings Hold Ratings Sell Ratings CCMConcord Medical Services Holdings Ltd.0 0 0 ZLABZai Lab Ltd.9 1 0 -
Is CCM or ZLAB More Risky?
Concord Medical Services Holdings Ltd. has a beta of -1.272, which suggesting that the stock is 227.222% less volatile than S&P 500. In comparison Zai Lab Ltd. has a beta of 0.835, suggesting its less volatile than the S&P 500 by 16.508%.
-
Which is a Better Dividend Stock CCM or ZLAB?
Concord Medical Services Holdings Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Zai Lab Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Concord Medical Services Holdings Ltd. pays -- of its earnings as a dividend. Zai Lab Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CCM or ZLAB?
Concord Medical Services Holdings Ltd. quarterly revenues are --, which are smaller than Zai Lab Ltd. quarterly revenues of $116.2M. Concord Medical Services Holdings Ltd.'s net income of -- is lower than Zai Lab Ltd.'s net income of -$36M. Notably, Concord Medical Services Holdings Ltd.'s price-to-earnings ratio is -- while Zai Lab Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Concord Medical Services Holdings Ltd. is 0.40x versus 4.49x for Zai Lab Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CCMConcord Medical Services Holdings Ltd.0.40x -- -- -- ZLABZai Lab Ltd.4.49x -- $116.2M -$36M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Planet Labs Stock Rally So Much?
Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…
Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
100
ATGL alert for Jan 10
Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.
Buy
65
RGC alert for Jan 10
Regencell Bioscience Holdings Ltd. [RGC] is up 10.55% over the past day.
Sell
50
NAIL alert for Jan 10
Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.
